Home › Funds › Silverberg Bernstein Capital Management LLC › NAGE
Silverberg Bernstein Capital Management LLC position in NAGE
NIAGEN BIOSCIENCE INC · Health Care
Silverberg Bernstein Capital Management LLC reported holding 137,952 shares of NAGE (NIAGEN BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$403K, representing 0.19% of its reported portfolio and ranking #47 among its reported holdings. Silverberg Bernstein Capital Management LLC has disclosed NAGE holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Silverberg Bernstein Capital Management LLC's NAGE position evolved
Silverberg Bernstein Capital Management LLC first disclosed a stake in NAGE in Q4 2023 at 82,757 shares (US$118K). The position peaked in Q2 2025 at 99,476 shares, worth US$1.4M. Across 12 filings, Silverberg Bernstein Capital Management LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 137,952 shares valued at US$403K — a reduction of -2,650 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 82.76K | $118.34K | New |
| Q1 2024 | 82.16K | $285.91K | Reduce |
| Q2 2024 | 82.16K | $224.29K | Hold |
| Q3 2024 | 83.26K | $303.89K | Add |
| Q4 2024 | 80.54K | $427.25K | Reduce |
| Q1 2025 | 95.54K | $659.21K | Add |
| Q2 2025 | 99.48K | $1.43M | Add |
| Q3 2025 | 125.26K | $1.17M | Add |
| Q4 2025 | 131.16K | $834.19K | Add |
| Q1 2026 | 138.10K | $609.03K | Add |
| Q2 2026 | 140.60K | $448.52K | Add |
| Q3 2026 | 137.95K | $402.82K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NAGE and 13F data
NAGE (NIAGEN BIOSCIENCE INC) is a Health Care company. 29 other funds we track also report a position in NAGE — the largest reported positions include Tieton Capital Management, LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NAGE
- Tieton Capital Management, LLC 2.01M sh · $6.41M · Q2 2026
More on Silverberg Bernstein Capital Management LLC
FAQ
How long has Silverberg Bernstein Capital Management LLC held NAGE?
Silverberg Bernstein Capital Management LLC has disclosed NAGE holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Silverberg Bernstein Capital Management LLC's current position in NAGE?
As of Q3 2026, Silverberg Bernstein Capital Management LLC holds 137.95K shares of NAGE (NIAGEN BIOSCIENCE INC), valued at $402.82K, representing 0.19% of its reported portfolio and ranking #47.
Has Silverberg Bernstein Capital Management LLC been buying or selling NAGE?
In the latest 13F filing (Q3 2026), Silverberg Bernstein Capital Management LLC reduced its position in NAGE. The position peaked in Q2 2025 at 99.48K shares.
Which other funds hold NAGE?
Other major institutional holders of NAGE include Tieton Capital Management, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.